Thomas Uhde to Double-Blind Method
This is a "connection" page, showing publications Thomas Uhde has written about Double-Blind Method.
Connection Strength
0.522
-
Heart rate and QT interval variability: abnormal alpha-2 adrenergic function in patients with panic disorder. Psychiatry Res. 2003 Dec 01; 121(2):185-96.
Score: 0.041
-
Electrical stimulation of the trigeminal nerve improves olfaction in healthy individuals: A randomized, double-blind, sham-controlled trial. Brain Stimul. 2022 May-Jun; 15(3):761-768.
Score: 0.037
-
Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls. Psychiatry Res. 1997 Jun 16; 71(1):27-39.
Score: 0.026
-
A comparison of the effects of intravenous pentagastrin on patients with social phobia, panic disorder and healthy controls. Neuropsychopharmacology. 1997 Mar; 16(3):229-37.
Score: 0.026
-
Role of serotonin drugs in the treatment of social phobia. J Clin Psychiatry. 1997; 58 Suppl 5:50-4.
Score: 0.026
-
Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry. 1994 Sep; 33(7):1000-6.
Score: 0.022
-
Lactic acid response to caffeine in panic disorder: comparison with social phobics and normal controls. Anxiety. 1994-1995; 1(3):138-40.
Score: 0.021
-
Dose-response effects of intravenous caffeine in normal volunteers. Anxiety. 1994-1995; 1(4):161-8.
Score: 0.021
-
Peptides and anxiety: a dose-response evaluation of pentagastrin in healthy volunteers. Anxiety. 1994-1995; 1(6):258-67.
Score: 0.021
-
Growth hormone response to intravenous clonidine in social phobia: comparison to patients with panic disorder and healthy volunteers. Biol Psychiatry. 1993 Nov 01; 34(9):591-5.
Score: 0.020
-
Blunted growth hormone responses to growth hormone-releasing factor and to clonidine in panic disorder. Am J Psychiatry. 1993 Feb; 150(2):336-7.
Score: 0.019
-
Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects. Biol Psychiatry. 1991 Nov 15; 30(10):973-84.
Score: 0.018
-
Effect of yohimbine on plasma homovanillic acid in panic disorder patients and normal controls. Biol Psychiatry. 1990 Aug 15; 28(4):292-6.
Score: 0.016
-
Growth hormone (GH) response to clonidine and growth hormone releasing factor (GRF) in normal controls. Psychoneuroendocrinology. 1990; 15(4):253-9.
Score: 0.016
-
Inefficacy of single-dose nifedipine in the treatment of phobic anxiety. Isr J Psychiatry Relat Sci. 1990; 27(2):119-23.
Score: 0.016
-
Plasma 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and growth hormone responses to yohimbine in panic disorder patients and normal controls. Psychoneuroendocrinology. 1990; 15(3):217-24.
Score: 0.016
-
Behavioral and physiologic effects of short-term and long-term administration of clonidine in panic disorder. Arch Gen Psychiatry. 1989 Feb; 46(2):170-7.
Score: 0.015
-
Controlled study of verapamil for treatment of panic disorder. Am J Psychiatry. 1988 Apr; 145(4):431-4.
Score: 0.014
-
Plasma adenosine levels: measurement in humans and relationship to the anxiogenic effects of caffeine. Psychiatry Res. 1987 Jul; 21(3):247-55.
Score: 0.013
-
Withdrawal syndrome with gradual tapering of alprazolam. Am J Psychiatry. 1986 Nov; 143(11):1464-6.
Score: 0.013
-
Effect of carbamazepine on body weight in affectively ill patients. J Clin Psychiatry. 1986 Jun; 47(6):313-4.
Score: 0.012
-
Are the psychotropic effects of carbamazepine in manic-depressive illness mediated through the limbic system? Psychiatr J Univ Ott. 1985 Dec; 10(4):205-19.
Score: 0.012
-
Carbamazepine in bipolar illness. Psychopharmacol Bull. 1985; 21(1):10-7.
Score: 0.011
-
Treatment of mood disorders with antiepileptic medications: clinical and theoretical implications. Epilepsia. 1983; 24 Suppl 2:S97-108.
Score: 0.010
-
Psychosis in the opioid addicted patient: assessment and treatment. J Clin Psychiatry. 1982 Jun; 43(6):240-7.
Score: 0.009
-
Biological relationships between mania and melancholia. Encephale. 1982; 8(2):213-28.
Score: 0.009
-
Clonidine suppresses the opioid abstinence syndrome without clonidine-withdrawal symptoms: a blind inpatient study. Psychiatry Res. 1980 Mar; 2(1):37-47.
Score: 0.008
-
Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med. 1994 May 19; 330(20):1411-7.
Score: 0.005
-
Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study. Arch Gen Psychiatry. 1991 Oct; 48(10):938-45.
Score: 0.004
-
Correlates of antimanic response to carbamazepine. Psychiatry Res. 1987 May; 21(1):71-83.
Score: 0.003
-
Antidepressant effects of carbamazepine. Am J Psychiatry. 1986 Jan; 143(1):29-34.
Score: 0.003
-
Relationship of response to sleep deprivation and carbamazepine in depressed patients. Acta Psychiatr Scand. 1984 May; 69(5):379-82.
Score: 0.003
-
Profile of clinical efficacy and side effect of carbamazepine in psychiatric illness: relationship to blood and CSF levels of carbamazepine and its -10,11-epoxide metabolite. Acta Psychiatr Scand Suppl. 1984; 313:104-20.
Score: 0.003
-
Prophylactic efficacy of carbamazepine in manic-depressive illness. Am J Psychiatry. 1983 Dec; 140(12):1602-4.
Score: 0.003
-
Biochemical effects of carbamazepine: relationship to its mechanisms of action in affective illness. Prog Neuropsychopharmacol Biol Psychiatry. 1983; 7(2-3):263-71.
Score: 0.002
-
Growth hormone response to clonidine unchanged by chronic clorgyline treatment. Psychiatry Res. 1982 Oct; 7(2):139-44.
Score: 0.002
-
Effect of carbamazepine on cyclic nucleotides in CSF of patients with affective illness. Biol Psychiatry. 1982 Sep; 17(9):1037-45.
Score: 0.002
-
Possible subsensitization of alpha 2-adrenergic receptors by chronic monoamine oxidase inhibitor treatment in psychiatric patients. Psychiatry Res. 1982 Jun; 6(3):293-302.
Score: 0.002
-
Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls. Psychiatry Res. 1982 Apr; 6(2):171-83.
Score: 0.002